These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. Zhan C, Gu B, Xie C, Li J, Liu Y, Lu W. J Control Release; 2010 Apr 02; 143(1):136-42. PubMed ID: 20056123 [Abstract] [Full Text] [Related]
4. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle. Rezazadeh M, Emami J, Hasanzadeh F, Sadeghi H, Minaiyan M, Mostafavi A, Rostami M, Lavasanifar A. Drug Deliv; 2016 Jun 02; 23(5):1707-17. PubMed ID: 25188785 [Abstract] [Full Text] [Related]
5. Radioluminescent nanoparticles for radiation-controlled release of drugs. Misra R, Sarkar K, Lee J, Pizzuti VJ, Lee DS, Currie MP, Torregrosa-Allen SE, Long DE, Durm GA, Langer MP, Elzey BD, Won YY. J Control Release; 2019 Jun 10; 303():237-252. PubMed ID: 31026550 [Abstract] [Full Text] [Related]
7. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells. Tong L, Chen W, Wu J, Li H. Anticancer Drugs; 2014 Mar 10; 25(3):244-54. PubMed ID: 24275314 [Abstract] [Full Text] [Related]
8. Folic Acid and Poly(ethylene glycol) Decorated Paclitaxel Nanocrystals Exhibit Enhanced Stability and Breast Cancer-Targeting Capability. Zhao J, Du J, Wang J, An N, Zhou K, Hu X, Dong Z, Liu Y. ACS Appl Mater Interfaces; 2021 Mar 31; 13(12):14577-14586. PubMed ID: 33728919 [Abstract] [Full Text] [Related]
9. CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer. Xue J, Li R, Gao D, Chen F, Xie H. Int J Nanomedicine; 2020 Mar 31; 15():5701-5718. PubMed ID: 32848392 [Abstract] [Full Text] [Related]
10. Folate-receptor-targeted laser-activable poly(lactide-co-glycolic acid) nanoparticles loaded with paclitaxel/indocyanine green for photoacoustic/ultrasound imaging and chemo/photothermal therapy. Liu F, Chen Y, Li Y, Guo Y, Cao Y, Li P, Wang Z, Gong Y, Ran H. Int J Nanomedicine; 2018 Mar 31; 13():5139-5158. PubMed ID: 30233177 [Abstract] [Full Text] [Related]
13. Hypocrellin B-loaded, folate-conjugated polymeric micelle for intraperitoneal targeting of ovarian cancer in vitro and in vivo. Li J, Yao S, Wang K, Lu Z, Su X, Li L, Yuan C, Feng J, Yan S, Kong B, Song K. Cancer Sci; 2018 Jun 31; 109(6):1958-1969. PubMed ID: 29617063 [Abstract] [Full Text] [Related]
15. Estrone-Conjugated PEGylated Liposome Co-Loaded Paclitaxel and Carboplatin Improve Anti-Tumor Efficacy in Ovarian Cancer and Reduce Acute Toxicity of Chemo-Drugs. Tang H, Xie Y, Zhu M, Jia J, Liu R, Shen Y, Zheng Y, Guo X, Miao D, Pei J. Int J Nanomedicine; 2022 Jun 31; 17():3013-3041. PubMed ID: 35836838 [Abstract] [Full Text] [Related]
16. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer. Lv W, Cheng L, Li B. Chem Pharm Bull (Tokyo); 2015 Jun 31; 63(2):68-74. PubMed ID: 25451039 [Abstract] [Full Text] [Related]
17. Optimization, Characterization and in vivo Evaluation of Paclitaxel-Loaded Folate-Conjugated Superparamagnetic Iron Oxide Nanoparticles. Gui G, Fan Z, Ning Y, Yuan C, Zhang B, Xu Q. Int J Nanomedicine; 2021 Jun 31; 16():2283-2295. PubMed ID: 33776433 [Abstract] [Full Text] [Related]
18. Co-delivery of paclitaxel (PTX) and docosahexaenoic acid (DHA) by targeting lipid nanoemulsions for cancer therapy. Li B, Tan T, Chu W, Zhang Y, Ye Y, Wang S, Qin Y, Tang J, Cao X. Drug Deliv; 2022 Dec 31; 29(1):75-88. PubMed ID: 34964421 [Abstract] [Full Text] [Related]
19. "OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo. Xiao K, Li Y, Lee JS, Gonik AM, Dong T, Fung G, Sanchez E, Xing L, Cheng HR, Luo J, Lam KS. Cancer Res; 2012 Apr 15; 72(8):2100-10. PubMed ID: 22396491 [Abstract] [Full Text] [Related]
20. Paclitaxel-loaded hyaluronan solid nanoemulsions for enhanced treatment efficacy in ovarian cancer. Kim JE, Park YJ. Int J Nanomedicine; 2017 Apr 15; 12():645-658. PubMed ID: 28176896 [Abstract] [Full Text] [Related] Page: [Next] [New Search]